Edition:
United States

Midatech Pharma PLC (MTP.OQ)

MTP.OQ on NASDAQ Stock Exchange Capital Market

0.77USD
21 Sep 2018
Change (% chg)

$0.04 (+5.43%)
Prev Close
$0.74
Open
$0.72
Day's High
$0.79
Day's Low
$0.72
Volume
5,803
Avg. Vol
8,031
52-wk High
$2.65
52-wk Low
$0.50

Latest Key Developments (Source: Significant Developments)

Midatech Pharma Says Approval Of Investigational New Drug Application From US FDA To Conduct Study Of MTX110
Tuesday, 16 Jan 2018 02:00am EST 

Jan 16 (Reuters) - Midatech Pharma Plc ::APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FROM US FDA TO CONDUCT A STUDY OF MTX110.MTX110 IS AN INVESTIGATIONAL NANO-INCLUSION PRODUCT, FOR TREATMENT OF FATAL CHILDHOOD BRAIN CANCER DIPG.  Full Article

Midatech Pharma Enters Into Four-Year Senior Secured Loan Agreement With Midcap Financial Of Up To $15 Mln​
Tuesday, 2 Jan 2018 07:00am EST 

Jan 2 (Reuters) - Midatech Pharma Plc ::MIDATECH PHARMA PLC - ‍HAS ENTERED INTO A FOUR-YEAR SENIOR SECURED LOAN AGREEMENT WITH MIDCAP FINANCIAL OF UP TO $15 MILLION​.  Full Article

Midatech Pharma U.S. Initiates Gelclair Phase IV Trial To Study Oral Mucositis In Stem Cell Transplant Patients
Wednesday, 20 Dec 2017 07:00am EST 

Dec 20 (Reuters) - Midatech Pharma Plc ::MIDATECH PHARMA US INITIATES GELCLAIR® PHASE IV TRIAL TO STUDY ORAL MUCOSITIS IN STEM CELL TRANSPLANT PATIENTS.MIDATECH PHARMA PLC - CO ANTICIPATES THAT PHASE IV TRIAL WILL COMPLETE ENROLLMENT IN H2 OF 2018.  Full Article

Midatech Pharma announces proposed placing and open offer
Thursday, 28 Sep 2017 02:00am EDT 

Sept 28 (Reuters) - MIDATECH PHARMA PLC ::PROPOSED PLACING TO RAISE UP TO APPROXIMATELY £6 MILLION AND OPEN OFFER TO RAISE UP TO £2 MILLION.NET PROCEEDS OF PLACING WILL PROVIDE COMPANY WITH ADDITIONAL WORKING CAPITAL TO FUND INVESTMENT IN PROGRESSING GROUP'S THREE LEAD DEVELOPMENT PROGRAMMES.  Full Article

Midatech Pharma provides trading update and notice of results
Tuesday, 18 Jul 2017 07:00am EDT 

July 18 (Reuters) - Midatech Pharma Plc ::Midatech Pharma Plc: trading update and notice of results.Midatech Pharma Plc - expects total gross revenues of approximately £5.2 million, a 37 pct increase from £3.8 million recorded in six months to June 2016.Midatech Pharma - company remains on-track to deliver market expectations for full year 2017.Midatech Pharma - anticipate similar revenue growth for H2 2017 compared to first half of year.Midatech Pharma - sales for second half of 2016 represented 59 pct of full year gross revenues and board anticipates a similar split in 2017.  Full Article

Midatech Pharma proceeds with testing for glioblastoma brain cancer
Monday, 22 May 2017 02:00am EDT 

May 22 (Reuters) - Midatech Pharma Plc ::Has selected its preferred candidate for testing in glioblastoma (gbm) brain cancer.Compound is under final evaluation with some key pre-clinical studies to confirm efficacy before being progressed into IND enabling trials.Additional candidates are also being evaluated in parallel.  Full Article